Skip to main content
TipRanks
Go Ultimate75% OFF

Lineage Therap (LCTX) Stock Forecast & Price Target

3 Followers
See the Price Targets and Ratings of:

LCTX Analyst Ratings

Moderate Buy
2Ratings
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to Lineage Therap in the past 3 months

LCTX Stock 12 Month Forecast

ILA 2,050.03▲(529.42% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Lineage Therap in the last 3 months. The average price target is ILA 2,050.03 with a high forecast of ILA 2,838.51 and a low forecast of ILA 1,261.56. The average price target represents a 529.42% change from the last price of ILA 325.70.
Highest Price TargetILA 2,838.51Average Price TargetILA 2,050.03Lowest Price TargetILA 1,261.56

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for IL:LCTX
Price TargetArticle
H.C. WainwrightILA 2,207.73→ILA 2,838.51buy771.51%UpsideReiterated10/29/26
B. Riley SecuritiesILA 1,261.56buy287.34%UpsideReiterated09/24/26
Maxim GroupILA 946.17buy190.50%UpsideReiterated08/11/26
Canaccord GenuityILA 2,838.51buy771.51%UpsideReiterated08/06/26
Craig-Hallum―buy―Reiterated07/14/26
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Lineage Therap

3 Months
Success Rate8/14 ratings generated profit
57%
Average Return
+28.82%

Copying Michael Okunewitch's trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +28.82% per trade.

1 Year
Success Rate8/14 ratings generated profit
57%
Average Return
+58.79%

Copying Michael Okunewitch's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +58.79% per trade.

2 Years
Success Rate9/14 ratings generated profit
64%
Average Return
+24.58%

Copying Michael Okunewitch's trades and holding each position for 2 Years would result in 64.29% of your transactions generating a profit, with an average return of +24.58% per trade.

LCTX Analyst Recommendation Trends

05101520Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for LCTX
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy64552
Buy11100
Hold00000
Sell00000
Strong Sell00000
total75652

In the current month, LCTX has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. LCTX average Analyst price target in the past 3 months is 2,050.03.

LCTX Financial Forecast

ILA -43ILA -31.8ILA -20.5ILA -9.25ILA 2Q4 2025Q2 2026Q3 2026
HighILA 0.00
ConsensusILA -9.23
LowILA -12.73

LCTX Earnings Forecast

Next quarter’s earnings estimate for LCTX is -ILA 9.23 with a range of -ILA 12.73 to ILA 0.00. The previous quarter’s EPS was -ILA 9.55. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.

ILA 340.3MILA 852MILA 1.4BILA 1.9BILA 2.4BQ4 2025Q2 2026Q3 2026
HighILA 2.39B
ConsensusILA 738M
LowILA 340M

LCTX Sales Forecast

Next quarter’s sales forecast for LCTX is ILA 737.81M with a range of ILA 340.26M to ILA 2.39B. The previous quarter’s sales results were ILA 340.26M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

LCTX Stock Forecast FAQ

What is IL:LCTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Lineage Therap’s 12-month average price target is ILA 2,050.03.
What is IL:LCTX’s upside potential, based on the analysts’ average price target?
Lineage Therap has 529.42% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Lineage Therap a Buy, Sell or Hold?
Lineage Therap has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Lineage Therap’s share price target?
The average share price target for Lineage Therap is ILA 2,050.03. This is based on 2 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is ILA 2,838.51, and the lowest forecast is ILA 1,261.56. The average share price target represents a 529.42% increase from the current price of ILA 325.7.
What do analysts say about Lineage Therap?
Lineage Therap’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of Lineage Therap?
To buy shares of IL:LCTX, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.